Alpha 2.0
Login Register
» Articles » PMID: 30894015

EGF (Epidermal Growth Factor) Receptor Ligands in Atrial Fibrillation: From Genomic Evidence to the Identification of New Players

Overview
Journal Circ Arrhythm Electrophysiol
Specialty Cardiology & Vascular Diseases
Date 2019 Mar 22
PMID 30894015
Citations 6
Authors
Petra Buttner
Sarah Werner
Philipp Sommer
Ralph Burkhardt
Samira Zeynalova
Ronny Baber
Andreas Bollmann
Daniela Husser-Bollmann
Joachim Thiery
Gerhard Hindricks
Holger Thiele
Jelena Kornej
Affiliations
Soon will be listed here.
Citing Articles

The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes.

Borlak J, Ciribilli Y, Bisio A, Selvaraj S, Inga A, Oh J J Transl Med. 2024; 22(1):845.

PMID: 39285385 PMC: 11403941. DOI: 10.1186/s12967-024-05623-8.

Transcriptional impact of EGFR activation in human female vascular smooth muscle cells.

Dubourg V, Schwerdt G, Schreier B, Kopf M, Mildenberger S, Benndorf R iScience. 2023; 26(11):108286.

PMID: 38026216 PMC: 10651680. DOI: 10.1016/j.isci.2023.108286.

The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system?.

Masbuchin A, Widodo , Rohman M, Liu P Front Cardiovasc Med. 2022; 9:986570.

PMID: 36237897 PMC: 9552878. DOI: 10.3389/fcvm.2022.986570.

Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm.

Yang L, Chen Y, Huang W Front Cardiovasc Med. 2022; 9:920399.

PMID: 35911532 PMC: 9329605. DOI: 10.3389/fcvm.2022.920399.

Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation.

Tan X, Xian W, Li X, Chen Y, Geng J, Wang Q Sci Rep. 2022; 12(1):9777.

PMID: 35697725 PMC: 9192746. DOI: 10.1038/s41598-022-13911-w.